These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7072415)

  • 1. [Thymus-dependent therapeutic immunosuppression in multiple sclerosis and myasthenia].
    Lobzin VS; Golovkin VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):176-81. PubMed ID: 7072415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunologic aspects of the pathogenesis and treatment of myasthenia].
    Lobzin VS; Golovkin VI; Chalov IuV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(8):1006-11. PubMed ID: 225910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasmapheresis in the treatment of neurologic disorders].
    Szobor A; Fornádi L; Vájlok M
    Orv Hetil; 1988 Jan; 129(3):119-23. PubMed ID: 3281091
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of thymus epithelial tissue in the formation of natural immune tolerance].
    Beletskaia LV; Gnezditskaia EV
    Usp Sovrem Biol; 1975; 79(1):128-37. PubMed ID: 1092082
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thymus-dependent and thymus-independent blood lymphocytes in multiple sclerosis].
    Khondkarian OA; Gannushkina IV; Zavalishin IA; Zhirnova IG; Nevskaia OM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(3):32-6. PubMed ID: 6602442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T lymphocytes modifying factors in sera of patients with Myasthenia gravis.
    Skibiński G; Ujma B; Guzowski K; Brzecki A; Zwoliński J; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1983; 31(1):43-50. PubMed ID: 6604510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia gravis.
    Simpson JA
    Practitioner; 1982 Jun; 226(1368):1045-50. PubMed ID: 7111137
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunological abnormalities in neuromuscular diseases].
    Nishitani H; Saida T; Ohta M; Kuno S
    No To Shinkei; 1983 Jun; 35(6):543-51. PubMed ID: 6354220
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma exchange in myasthenia gravis and multiple sclerosis.
    Balint B; Jovicić A; Apostolski S; Magdić B; Taseski J
    Vojnosanit Pregl; 2000; 57(5):11-5. PubMed ID: 11213670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [B cell population and its autoimmune activity in the thymus of patients associated with myasthenia gravis].
    Yoshitake T; Takahama T; Kanai F; Ohnishi K; Suzuki T; Kametani Y; Itoyama S; Sugawara I; Matsunaga A
    Kyobu Geka; 1993 Dec; 46(13):1083-7; discussion 1087-9. PubMed ID: 8258907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thymus gland and myasthenia].
    Canal N
    Riv Neurobiol; 1974; 20(14):28-33. PubMed ID: 4471376
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoimmune diseases of the nervous system.
    Behan PO; Johnson RH
    Practitioner; 1975 Apr; 214(1282):522-532. PubMed ID: 1096126
    [No Abstract]   [Full Text] [Related]  

  • 13. Extrathymic tumors in patients with myasthenia gravis: a 35-year retrospective study.
    Wakata N; Sugimoto H; Nomoto N; Konno S; Nakazora H; Nemoto H; Karihara T
    Neurologist; 2006 Jan; 12(1):53-5. PubMed ID: 16547448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation between pathogenesis of myasthenia gravis and thymus mature dendritic cells].
    Xia Q; Liu WB; Feng HY; Chen ZG; Zhang Y; He XT
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(47):3349-51. PubMed ID: 19257967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCR-Vbeta usage in the thymus and blood of myasthenia gravis patients.
    Navaneetham D; Penn AS; Howard JF; Conti-Fine BM
    J Autoimmun; 1998 Dec; 11(6):621-33. PubMed ID: 9878084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenia gravis: an example of receptor disease.
    Conti-Tronconi BM; Fumagalli G; Scotti A; Brigonzi A; Sher E; Morgutti M; Clementi F
    Adv Biochem Psychopharmacol; 1980; 21():473-88. PubMed ID: 7376974
    [No Abstract]   [Full Text] [Related]  

  • 17. The thymus and myasthenia gravis: immunological and neurophysiological aspects.
    Carrieri PB; Marano E; Perretti A; Caruso G
    Ann Med; 1999 Oct; 31 Suppl 2():52-6. PubMed ID: 10574156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thoracic duct lymphocyte depletion in myasthenia gravis.
    Tindall SC; Peters BH; Caverley JR; Sarles HE; Fish JC
    Arch Neurol; 1973 Sep; 29(3):202-3. PubMed ID: 4544333
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative analysis of T and B-cell subpopulations in normal thymus and thymus of myasthenia gravis.
    Wada H; Matsunobe S; Ito M; Teramatsu T
    Bull Chest Dis Res Inst Kyoto Univ; 1980 Mar; 13(1-2):19-24. PubMed ID: 6985458
    [No Abstract]   [Full Text] [Related]  

  • 20. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
    Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.